Paul D. Burgess - Jun 20, 2023 Form 3 Insider Report for Cerevel Therapeutics Holdings, Inc. (CERE)

Role
Title: Chief Business Development and Strategic Operations Officer. Exhibit 24 - Power of Attorney
Signature
/s/ Mark Bodenrader, as Attorney-in-Fact
Stock symbol
CERE
Transactions as of
Jun 20, 2023
Transactions value $
$0
Form type
3
Date filed
6/28/2023, 06:59 PM
Previous filing
Sep 14, 2021
Next filing
Jul 6, 2023

No securities are beneficially owned.

Remarks:

Title: Chief Business Development and Strategic Operations Officer. Exhibit 24 - Power of Attorney